Lead Scientist
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Mariateresa Fulciniti, PhD
Lead scientist
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute.
Boston (MA), USA
Dr. Fulciniti received her BS/MS degree in biological sciences from the University of Calabria, Italy, in 2004. She obtained a PhD in Molecular Oncology from the University of Magna Graecia, Italy, in 2009, after spending two years as visiting PhD student at Dana-Farber Cancer Institute, Boston, USA. In 2013, she became Instructor in Medicine at the Harvard Medical School. She’s currently Lead Scientist in the Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute (Boston, USA)
Dr Fulciniti’s research is an example of the Bench to Bedside and Bedside to Bench translational research approach. Her research focuses on identifying new druggable dependencies and developing novel therapeutic strategies for the treatment of multiple myeloma and related plasma cell disorders. Specifically, her research aims at elucidating key cellular signaling pathways that contribute to the survival and proliferation of myeloma cells in the microenvironment, including immune escape, as well as the mechanisms driving intrinsic and acquired drug resistance in myeloma by integrative epigenomic and genomic parameters. She has published widely on multiple myeloma and is an ad hoc reviewer for several scientific journals.
Meet the Professor: Optimizing in vitro cellular models of MM
Friday, September 29, 2023
7:00 AM – 8:00 AM EEST